SPOTLIGHT: Clinical Data upbeat on antidepressant

Shares of Clinical Data got a modest boost on the news that its late-stage study of the antidepressant Vilazodone produced positive results. A companion pharmacogenetic test may make it easier to identify the patients most likely to benefit. Release

Suggested Articles

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.

Pfizer's eczema hopeful has been building its case to challenge Sanofi and Regeneron's Dupixent, but safety issues could stand in its way.

Cedrik Britten, M.D., becomes the biotech’s new chief medical officer to help run its adoptive cell therapy and TCR bispecifics platform.